Oregon is denying hundreds of students with disabilities the right to a full school day in violation of federal laws, and state education officials need to ensure that schools can and do provide them the complete and meaningful education to which they are entitled, say the advocates and parents behind a federal class action lawsuit filed Tuesday.
Bangor, Maine resident John Hiatt, who has autism, was elected to the Bangor school committee and to the position of county treasurer last November.
Laughter echoed through the dimly lit room as the teens stretched their backs and, on their hands and knees, wagged their “tails.” They let out high-pitched cat meows and bellowed deep cow moos, mimicking the animals described in a storybook.
Step into the massive greenhouse at Lettuce Work Farms and you’re faced with leafy green plants as far as the eye can see.
Earlier this month, a Kentucky teacher was charged with assault after a video showed her dragging a 9-year-old boy with autism through school hallways.
Founder Amy Wright has two children with Down syndrome, Bitty and Beau, who the coffee shop is named after. She was aware that a majority of adults with intellectual and developmental disabilities are unemployed. Wright was determined to be part of the solution.
KING 5's Susannah Frame and Taylor Mirfendereski expose the reasons why Washington lags behind much of the country in serving one of its most vulnerable populations: students with disabilities.
PULLMAN – Evan Henniger always felt drawn to Washington State University.
His parents never thought college would be a possibility. Evan, 20, was diagnosed with Down syndrome shortly after his birth, and the prospect of venturing away from home on his own seemed unlikely.
A 9-year-old girl who almost gave up on recess because it took too long to bundle up has joined her mom in helping other kids around the world. Zoey Harrison loves playing outside with her friends, but was running into some trouble when it came to keeping warm while sitting in her wheelchair.
The Food and Drug Administration has fast-tracked L1-79, a drug designed to treat the “core symptoms” of autism. This is the second drug for autism that has received an accelerated approval process from the FDA in 2018.